GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ginwa Enterprise Group Inc (SHSE:600080) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Ginwa Enterprise Group (SHSE:600080) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 29, 2025)


View and export this data going back to 1997. Start your Free Trial

What is Ginwa Enterprise Group Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Ginwa Enterprise Group's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Ginwa Enterprise Group's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Ginwa Enterprise Group's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ginwa Enterprise Group's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ginwa Enterprise Group's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Ginwa Enterprise Group's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Ginwa Enterprise Group  (SHSE:600080) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Ginwa Enterprise Group Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Ginwa Enterprise Group's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ginwa Enterprise Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ginwa Enterprise Group Inc (SHSE:600080) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
SZSE:000153 SHSE:600568 SZSE:301331 SHSE:603168 SHSE:603079 SZSE:002940 SZSE:002412 SZSE:301520 SHSE:600513 SZSE:300534 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Gaoxin 3rd Road, 40th Floor, South Tower, Phase III, Fortune Center, Gaoxin District, Xi'an, CHN, 710075
Website
http://www.ginwa.com
Ginwa Enterprise Group Inc operates in the pharmaceutical industry. The main business is the research and development, production, and sales of drugs, and the product line covers chemical drugs, Chinese patent medicines, raw materials, and health products. The dosage forms include tablets, capsules, granules, powders, mixtures, oral solutions, syrups, external solutions, and more than 100 varieties and specifications.
Executives
Zhang Chao Yang Director
Zhang Mei Director
Tao Yu senior management
Qin Chuan Director
Hou Yi Wen senior management
Ge Xiu Li Supervisors

Ginwa Enterprise Group Headlines

No Headlines